Highlights
NASDAQ: KZIA       Kazia Therapeutics Ltd
Last Price Today's Change   Day's Range   Trading Volume
6.80   -0.16 (2.30%)  6.55 - 7.04  28,230

Overview

 
Avg Volume (4 weeks):175,984
4 Weeks Range:6.51 - 8.53
4 Weeks Price Volatility (%):
14.36%
52 Weeks Range:2.47 - 9.74
52 Weeks Price Volatility (%):
59.56%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The company has three technologies – PI3K inhibitors, superbenzopyran, and anti-tropomyosin. The group is developing GDC-0084, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; Trilexium, has a potential application across a range of different cancer types.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

2010  3947  233  3092 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AAPL 106.84-3.50 
 LK 1.38+1.38 
 KODK 12.11+1.41 
 ONTX 0.322+0.072 
 GE 6.88-0.17 
 SAVA 10.07+2.98 
 SQQQ 27.48+1.06 
 WFC 25.13+0.02 
 TSLA 442.15+18.72 
 RIG 1.06-0.05 
PARTNERS & BROKERS